The White House has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration. The decision ends a nomination that had stalled amid concerns over her positions on abortion and vaccines.
The Senate health committee had been scheduled to vote on her nomination Wednesday morning. The panel had spent weeks weighing those concerns before the vote was set.
Overton’s stance on abortion drew scrutiny from senators on both sides of the aisle. Her views on vaccine policy also raised questions during the confirmation process.
The withdrawal leaves the FDA without a permanent commissioner at a critical time. The agency oversees drug approvals, food safety, and vaccine regulation.
Senators on the health committee had wrestled with how to handle the nomination in recent days. The scheduled Wednesday vote signaled the panel was prepared to move forward before the White House acted.
It remains unclear who the administration will nominate to replace Overton. No timeline has been announced for a new pick.
The FDA has been led by an acting commissioner during the vacancy. The agency continues to carry out its regulatory duties while the leadership question remains unresolved.




